93 related articles for article (PubMed ID: 12187099)
1. MCP-1 and RANTES are expressed in renal cortex of rats chronically treated with nitric oxide synthase inhibitor. Involvement in macrophage and monocyte recruitment.
Kashiwagi M; Masutani K; Shinozaki M; Hirakata H
Nephron; 2002 Sep; 92(1):165-73. PubMed ID: 12187099
[TBL] [Abstract][Full Text] [Related]
2. Expression of the chemokines MCP-1/CCL2 and RANTES/CCL5 is differentially regulated by infiltrating inflammatory cells.
Haberstroh U; Pocock J; Gómez-Guerrero C; Helmchen U; Hamann A; Gutierrez-Ramos JC; Stahl RA; Thaiss F
Kidney Int; 2002 Oct; 62(4):1264-76. PubMed ID: 12234296
[TBL] [Abstract][Full Text] [Related]
3. Systemic Aldosterone, But Not Angiotensin II, Plays a Pivotal Role in the Pathogenesis of Renal Injury in Chronic Nitric Oxide-Deficient Male Rats.
Suehiro T; Tsuruya K; Ikeda H; Toyonaga J; Yamada S; Noguchi H; Tokumoto M; Kitazono T
Endocrinology; 2015 Jul; 156(7):2657-66. PubMed ID: 25872005
[TBL] [Abstract][Full Text] [Related]
4. Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat.
Uhlenius N; Vuolteenaho O; Tikkanen I
J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):233-9. PubMed ID: 11881129
[TBL] [Abstract][Full Text] [Related]
5. Locally activated renin-angiotensin system associated with TGF-beta1 as a major factor for renal injury induced by chronic inhibition of nitric oxide synthase in rats.
Kashiwagi M; Shinozaki M; Hirakata H; Tamaki K; Hirano T; Tokumoto M; Goto H; Okuda S; Fujishima M
J Am Soc Nephrol; 2000 Apr; 11(4):616-624. PubMed ID: 10752520
[TBL] [Abstract][Full Text] [Related]
6. Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine.
Toba H; Nakagawa Y; Miki S; Shimizu T; Yoshimura A; Inoue R; Asayama J; Kobara M; Nakata T
Hypertens Res; 2005 Aug; 28(8):689-700. PubMed ID: 16392774
[TBL] [Abstract][Full Text] [Related]
7. The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats.
Siragy HM; Carey RM
J Clin Invest; 1997 Jul; 100(2):264-9. PubMed ID: 9218502
[TBL] [Abstract][Full Text] [Related]
8. Time course of cardiac inflammation during nitric oxide synthase inhibition in SHR: impact of prior transient ACE inhibition.
Biwer LA; D'souza KM; Abidali A; Tu D; Siniard AL; DeBoth M; Huentelman M; Hale TM
Hypertens Res; 2016 Jan; 39(1):8-18. PubMed ID: 26490086
[TBL] [Abstract][Full Text] [Related]
9. L-arginine suppresses lipopolysaccharide-induced expression of RANTES in glomeruli.
Haberstroh U; Stilo K; Pocock J; Wolf G; Helmchen U; Wenzel U; Zahner G; Stahl RA; Thaiss F
J Am Soc Nephrol; 1998 Feb; 9(2):203-10. PubMed ID: 9527396
[TBL] [Abstract][Full Text] [Related]
10. Statin monotherapy attenuates renal injury in a salt-sensitive hypertension model of renal disease.
Vieira JM; Rodrigues LT; Mantovani E; Dellê H; Mattar AL; Malheiros DM; Noronha IL; Fujihara CK; Zatz R
Nephron Physiol; 2005; 101(4):p82-91. PubMed ID: 16113589
[TBL] [Abstract][Full Text] [Related]
11. Early co-expression of cyclooxygenase-2 and renin in the rat kidney cortex contributes to the development of N(G)-nitro-L-arginine methyl ester induced hypertension.
Guzmán-Hernández EA; Villalobos-Molina R; Sánchez-Mendoza MA; Del Valle-Mondragón L; Pastelín-Hernández G; Ibarra-Barajas M
Can J Physiol Pharmacol; 2015 Apr; 93(4):299-308. PubMed ID: 25761067
[TBL] [Abstract][Full Text] [Related]
12. Effects of prostaglandins and nitric oxide on the renal effects of angiotensin II in the anaesthetized rat.
Clayton JS; Clark KL; Johns EJ; Drew GM
Br J Pharmacol; 1998 Aug; 124(7):1467-74. PubMed ID: 9723960
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide synthase inhibition accelerates the pressor response to low-dose angiotensin II, exacerbates target organ damage, and induces renin escape.
Hu L; Sealey JE; Chen R; Zhou Y; Merali C; Shi Y; Laragh JH; Catanzaro DF
Am J Hypertens; 2004 May; 17(5 Pt 1):395-403. PubMed ID: 15110897
[TBL] [Abstract][Full Text] [Related]
14. DNA vaccination with naked DNA encoding MCP-1 and RANTES protects against renal injury in adriamycin nephropathy.
Wu H; Wang Y; Tay YC; Zheng G; Zhang C; Alexander SI; Harris DC
Kidney Int; 2005 Jun; 67(6):2178-86. PubMed ID: 15882261
[TBL] [Abstract][Full Text] [Related]
15. Changes in angiotensin AT1 receptor mRNA levels in the rat brain after immobilization stress and inhibition of central nitric oxide synthase.
Kiss A; Jurkovicova D; Jezova D; Krizanova O
Endocr Regul; 2001 Jun; 35(2):65-70. PubMed ID: 11563933
[TBL] [Abstract][Full Text] [Related]
16. AT2-antagonist sensitive potentiation of angiotensin II-induced vasoconstrictions by blockade of nitric oxide synthesis in rat renal vasculature.
Muller C; Endlich K; Barthelmebs M; Helwig JJ
Br J Pharmacol; 1997 Dec; 122(7):1495-501. PubMed ID: 9421301
[TBL] [Abstract][Full Text] [Related]
17. Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling.
Ishibashi M; Hiasa K; Zhao Q; Inoue S; Ohtani K; Kitamoto S; Tsuchihashi M; Sugaya T; Charo IF; Kura S; Tsuzuki T; Ishibashi T; Takeshita A; Egashira K
Circ Res; 2004 May; 94(9):1203-10. PubMed ID: 15059935
[TBL] [Abstract][Full Text] [Related]
18. Central and peripheral mechanisms involved in hypertension induced by chronic inhibition of nitric oxide synthase in rats.
Liu Y; Tsuchihashi T; Kagiyama S; Matsumura K; Abe I; Fujishima M
J Hypertens; 1998 Aug; 16(8):1165-73. PubMed ID: 9794721
[TBL] [Abstract][Full Text] [Related]
19. Cardiac angiotensin II receptors are upregulated by long-term inhibition of nitric oxide synthesis in rats.
Katoh M; Egashira K; Usui M; Ichiki T; Tomita H; Shimokawa H; Rakugi H; Takeshita A
Circ Res; 1998 Oct; 83(7):743-51. PubMed ID: 9758645
[TBL] [Abstract][Full Text] [Related]
20. Renoprotective effects of captopril in hypertension induced by nitric oxide synthase inhibition in experimental nephritis.
Uhlenius N; Tikkanen T; Miettinen A; Holthöfer H; Törnroth T; Eriksson A; Fyhrquist F; Tikkanen I
Nephron; 1999 Feb; 81(2):221-9. PubMed ID: 9933759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
